Ono Pharmaceutical Ratios and Metrics

Market cap in millions EUR. Fiscal year is April - March.

Millions EUR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan '26 Jan 28, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	5,901	4,651	7,065	9,345	11,215	11,112
Market Cap Growth	23.29%	-34.18%	-24.40%	-16.67%	0.92%	5.90%
Enterprise Value	5,650	4,583	6,528	8,696	10,861	10,529
Last Close Price	12.20	9.52	13.82	16.74	19.44	-
PE Ratio	21.13	15.04	9.01	11.97	18.79	19.13
PS Ratio	2.03	1.55	2.29	3.02	4.19	4.66
PB Ratio	1.26	0.96	1.44	1.81	2.29	2.25
P/TBV Ratio	2.42	1.75	1.57	2.01	2.56	2.55
P/FCF Ratio	10.70	9.77	10.81	8.75	26.86	21.54
P/OCF Ratio	10.02	9.13	10.42	8.46	24.47	19.50
EV/Sales Ratio	2.06	1.52	2.12	2.81	4.05	4.42
EV/EBITDA Ratio	10.96	8.36	5.97	7.50	11.40	11.93
EV/EBIT Ratio	17.83	12.00	6.65	8.37	13.22	13.84
EV/FCF Ratio	10.24	9.63	9.99	8.14	26.01	20.41
Debt / Equity Ratio	0.16	0.19	0.01	0.01	0.01	0.01
Debt / EBITDA Ratio	1.38	1.65	0.05	0.05	0.07	0.08
Debt / FCF Ratio	1.36	1.90	0.08	0.06	0.16	0.14
Asset Turnover	0.48	0.49	0.56	0.55	0.49	0.44
Inventory Turnover	2.69	2.40	2.72	2.54	2.31	2.38
Quick Ratio	2.29	2.32	2.92	1.71	2.56	1.58
Current Ratio	2.99	3.07	3.99	2.81	4.27	2.64
Return on Equity (ROE)	6.06%	6.32%	16.56%	16.02%	12.39%	12.49%
Return on Assets (ROA)	3.44%	3.91%	11.16%	11.57%	9.32%	8.69%
Return on Invested Capital (ROIC)	6.43%	7.64%	19.25%	18.70%	14.34%	13.52%
Return on Capital Employed (ROCE)	6.30%	6.70%	19.80%	19.80%	16.50%	15.10%
Earnings Yield	4.73%	6.65%	11.10%	8.35%	5.32%	5.23%
FCF Yield	9.35%	10.23%	9.25%	11.43%	3.72%	4.64%
Dividend Yield	3.86%	5.19%	3.55%	2.90%	2.14%	-
Payout Ratio	77.38%	74.96%	29.05%	26.38%	34.36%	29.76%
Buyback Yield / Dilution	0.45%	2.14%	1.70%	1.65%	0.54%	0.96%
Total Shareholder Return	4.30%	7.33%	5.25%	4.54%	2.67%	0.96%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.